Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S de Bono

Showing results (131-140 of 492) with videos related to

Pageof 50
Sort By:
Nature Reviews. Drug Discovery|July 23, 2016
Drug discovery in advanced prostate cancer: translating biology into therapyTimothy A Yap, Alan D Smith, Roberta Ferraldeschi, et al.
Histopathology|July 22, 2014
Sarcomatoid carcinoma of the prostate: ERG fluorescence in-situ hybridization confirms epithelial originDaniel Nava Rodrigues, Steve Hazell, Susana Miranda, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 16, 2017
Comparison of Timed Automata with Discrete Event Simulation for Modeling of Biomarker-Based Treatment Decisions: An Illustration for Metastatic Castration-Resistant Prostate CancerKoen Degeling, Stefano Schivo, Niven Mehra, et al.
Nature Reviews. Urology|January 8, 2015
Switching and withdrawing hormonal agents for castration-resistant prostate cancerDavid Lorente, Joaquin Mateo, Zafeiris Zafeiriou, et al.
Current Opinion in Pharmacology|August 30, 2008
Targeting the PI3K-AKT-mTOR pathway: progress, pitfalls, and promisesTimothy A Yap, Michelle D Garrett, Mike I Walton, et al.
European Radiology|June 29, 2011
Assessing response in bone metastases in prostate cancer with diffusion weighted MRIC Messiou, D J Collins, S Giles, et al.
Skeletal Radiology|November 26, 2013
Use of apparent diffusion coefficient as a response biomarker in bone: effect of developing sclerosis on quantified valuesC Messiou, D J Collins, V A Morgan, et al.
The Lancet. Oncology|February 14, 2009
Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial dataHoward I Scher, Xiaoyu Jia, Johann S de Bono, et al.
Clinical Genitourinary Cancer|March 4, 2015
Analysis of Side Effect Profile of Alopecia, Nail Changes, Peripheral Neuropathy, and Dysgeusia in Prostate Cancer Patients Treated With Docetaxel and CabazitaxelAurelius Omlin, Oliver Sartor, Christian Rothermundt, et al.
British Journal of Cancer|August 17, 2000
Improving the outcome of salvage treatment for non-seminomatous germ cell tumours (NSGCT)J S de Bono, J Paul, A Simpson, et al.
Pageof 50

Showing results (131-140 of 492) with videos related to

Sort By:
Pageof 50
Nature Reviews. Drug Discovery|July 23, 2016
Drug discovery in advanced prostate cancer: translating biology into therapyTimothy A Yap, Alan D Smith, Roberta Ferraldeschi, et al.
Histopathology|July 22, 2014
Sarcomatoid carcinoma of the prostate: ERG fluorescence in-situ hybridization confirms epithelial originDaniel Nava Rodrigues, Steve Hazell, Susana Miranda, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 16, 2017
Comparison of Timed Automata with Discrete Event Simulation for Modeling of Biomarker-Based Treatment Decisions: An Illustration for Metastatic Castration-Resistant Prostate CancerKoen Degeling, Stefano Schivo, Niven Mehra, et al.
Nature Reviews. Urology|January 8, 2015
Switching and withdrawing hormonal agents for castration-resistant prostate cancerDavid Lorente, Joaquin Mateo, Zafeiris Zafeiriou, et al.
Current Opinion in Pharmacology|August 30, 2008
Targeting the PI3K-AKT-mTOR pathway: progress, pitfalls, and promisesTimothy A Yap, Michelle D Garrett, Mike I Walton, et al.
European Radiology|June 29, 2011
Assessing response in bone metastases in prostate cancer with diffusion weighted MRIC Messiou, D J Collins, S Giles, et al.
Skeletal Radiology|November 26, 2013
Use of apparent diffusion coefficient as a response biomarker in bone: effect of developing sclerosis on quantified valuesC Messiou, D J Collins, V A Morgan, et al.
The Lancet. Oncology|February 14, 2009
Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial dataHoward I Scher, Xiaoyu Jia, Johann S de Bono, et al.
Clinical Genitourinary Cancer|March 4, 2015
Analysis of Side Effect Profile of Alopecia, Nail Changes, Peripheral Neuropathy, and Dysgeusia in Prostate Cancer Patients Treated With Docetaxel and CabazitaxelAurelius Omlin, Oliver Sartor, Christian Rothermundt, et al.
British Journal of Cancer|August 17, 2000
Improving the outcome of salvage treatment for non-seminomatous germ cell tumours (NSGCT)J S de Bono, J Paul, A Simpson, et al.
Pageof 50